Cargando…

A disease, disorder, illness or condition: How to label epilepsy?

The International League Against Epilepsy (ILAE) is an important source of guidance for health professionals when it comes to epilepsy. Their latest recommendation that epilepsy should no longer be called a “disorder,” but a “disease” has though caused controversy. The ILAE contends the change will...

Descripción completa

Detalles Bibliográficos
Autores principales: Noble, A. J., Robinson, A., Marson, A. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655763/
https://www.ncbi.nlm.nih.gov/pubmed/28294303
http://dx.doi.org/10.1111/ane.12757
_version_ 1783273598492868608
author Noble, A. J.
Robinson, A.
Marson, A. G.
author_facet Noble, A. J.
Robinson, A.
Marson, A. G.
author_sort Noble, A. J.
collection PubMed
description The International League Against Epilepsy (ILAE) is an important source of guidance for health professionals when it comes to epilepsy. Their latest recommendation that epilepsy should no longer be called a “disorder,” but a “disease” has though caused controversy. The ILAE contends the change will improve epilepsy's image. Some clinicians and other organizations fear the change may not though be accepted by patients as in common parlance “disease” can be associated with “contagiousness”/”infection.” To allow practicing clinicians to make informed judgements about what language they use, we completed the first study to assess the preferences of those with epilepsy and significant others and explore if any of their characteristics were associated with preference. Via epilepsy interest groups and associations in England, Wales, Scotland and the Republic of Ireland, 971 patients and significant others were surveyed. Participants identified which of four labels for epilepsy (“disorder,” “illness,” “disease,” “condition”) they favoured and rated each using a Likert‐scale. Patients’ median age was 39; 69% had experienced seizures in the prior year. “Condition” was favoured by most patients (74.3%) and significant others (71.2%). Only 2.2% of patients and 1.2% of significant others chose “disease”; it received a median Likert‐rating indicating “strongly dislike.” Multinomial logistic regression found it was not possible to reliably distinguish between participants favouring the different terms on the basis of demographics. The ILAE's position is at odds with what most patients and carers want and we discuss the implications of this.
format Online
Article
Text
id pubmed-5655763
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56557632017-11-01 A disease, disorder, illness or condition: How to label epilepsy? Noble, A. J. Robinson, A. Marson, A. G. Acta Neurol Scand Clinical Commentary The International League Against Epilepsy (ILAE) is an important source of guidance for health professionals when it comes to epilepsy. Their latest recommendation that epilepsy should no longer be called a “disorder,” but a “disease” has though caused controversy. The ILAE contends the change will improve epilepsy's image. Some clinicians and other organizations fear the change may not though be accepted by patients as in common parlance “disease” can be associated with “contagiousness”/”infection.” To allow practicing clinicians to make informed judgements about what language they use, we completed the first study to assess the preferences of those with epilepsy and significant others and explore if any of their characteristics were associated with preference. Via epilepsy interest groups and associations in England, Wales, Scotland and the Republic of Ireland, 971 patients and significant others were surveyed. Participants identified which of four labels for epilepsy (“disorder,” “illness,” “disease,” “condition”) they favoured and rated each using a Likert‐scale. Patients’ median age was 39; 69% had experienced seizures in the prior year. “Condition” was favoured by most patients (74.3%) and significant others (71.2%). Only 2.2% of patients and 1.2% of significant others chose “disease”; it received a median Likert‐rating indicating “strongly dislike.” Multinomial logistic regression found it was not possible to reliably distinguish between participants favouring the different terms on the basis of demographics. The ILAE's position is at odds with what most patients and carers want and we discuss the implications of this. John Wiley and Sons Inc. 2017-03-14 2017-11 /pmc/articles/PMC5655763/ /pubmed/28294303 http://dx.doi.org/10.1111/ane.12757 Text en © 2017 The Authors. Acta Neurologica Scandinavica Published by John Wiley & Sons Ltd This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Commentary
Noble, A. J.
Robinson, A.
Marson, A. G.
A disease, disorder, illness or condition: How to label epilepsy?
title A disease, disorder, illness or condition: How to label epilepsy?
title_full A disease, disorder, illness or condition: How to label epilepsy?
title_fullStr A disease, disorder, illness or condition: How to label epilepsy?
title_full_unstemmed A disease, disorder, illness or condition: How to label epilepsy?
title_short A disease, disorder, illness or condition: How to label epilepsy?
title_sort disease, disorder, illness or condition: how to label epilepsy?
topic Clinical Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655763/
https://www.ncbi.nlm.nih.gov/pubmed/28294303
http://dx.doi.org/10.1111/ane.12757
work_keys_str_mv AT nobleaj adiseasedisorderillnessorconditionhowtolabelepilepsy
AT robinsona adiseasedisorderillnessorconditionhowtolabelepilepsy
AT marsonag adiseasedisorderillnessorconditionhowtolabelepilepsy
AT nobleaj diseasedisorderillnessorconditionhowtolabelepilepsy
AT robinsona diseasedisorderillnessorconditionhowtolabelepilepsy
AT marsonag diseasedisorderillnessorconditionhowtolabelepilepsy